NF-κB Inhibitor Myrislignan Induces Ferroptosis of Glioblastoma Cells via Regulating Epithelial-Mesenchymal Transformation in a Slug-Dependent Manner

Figure 1

Myrislignan suppressed the growth and EMT status of GBM cells. (a) The molecular structure of myrislignan. (b, c) The cell viability of U87 and U251 was detected after treatment with increasing concentrations of myrislignan. (d–g) Transwell assay was performed to assess the migration ability of U87 and U251 cells after myrislignan treatment. Scale bar, 20 μm. (h–k) Wound-healing assay was performed in U87 and U251 cells treated with myrislignan at different concentrations. Results were obtained in three independent experiments and quantified. ; ; .

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)